The FDA’s pivot from ad comms to ‘expert’ panels is bad medicine These panels are a retreat from transparency, scientific rigor, and public accountability

https://www.statnews.com/2025/09/05/fda-expert-panels-advisory-committees-talc-ssris-formula/